# | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
---|---|---|---|---|---|---|---|---|---|
1. | ALA3224132 | Functional | Ratio of oseltamivir carboxylate EC50 to compound EC50 for Influenza B virus (B/Harbin/07/94) infected in MDCK cells assessed as reduction of virus-induced cytopathic effect after 72 hrs by MTT assay | Influenza B virus | 4 | ALA3217741 | cell-based format | Scientific Literature | |
2. | ALA3224133 | Functional | Ratio of zanamivir EC50 to compound EC50 for Influenza B virus (B/Harbin/07/94) infected in MDCK cells assessed as reduction of virus-induced cytopathic effect after 72 hrs by MTT assay | Influenza B virus | 4 | ALA3217741 | cell-based format | Scientific Literature | |
3. | ALA3224134 | Functional | Ratio of zanamivir EC50 to compound EC50 for Influenza A virus (A/Sydney/5/1997(H3N2)) infected in MDCK cells assessed as reduction of virus-induced cytopathic effect after 72 hrs by MTT assay | Influenza A virus (A/Sydney/5/1997(H3N2)) | 4 | ALA3217741 | cell-based format | Scientific Literature | |
4. | ALA3224135 | Functional | Ratio of oseltamivir carboxylate EC50 to compound EC50 for Influenza A virus (A/Sydney/5/1997(H3N2)) infected in MDCK cells assessed as reduction of virus-induced cytopathic effect after 72 hrs by MTT assay | Influenza A virus (A/Sydney/5/1997(H3N2)) | 4 | ALA3217741 | cell-based format | Scientific Literature | |
5. | ALA3224136 | Functional | Antiviral activity against Influenza B virus (B/Harbin/07/94) infected in MDCK cells assessed as reduction of virus-induced cytopathic effect after 72 hrs by MTT assay | Influenza B virus | 9 | ALA3217741 | cell-based format | Scientific Literature | |
6. | ALA3224508 | Functional | Antiviral activity against Influenza A virus (A/Sydney/5/1997(H3N2)) infected in MDCK cells assessed as reduction of virus-induced cytopathic effect after 72 hrs by MTT assay | Influenza A virus (A/Sydney/5/1997(H3N2)) | 9 | ALA3217741 | cell-based format | Scientific Literature |